Waterfield A A, Leslie F M, Lord J A, Ling N, Kosterlitz H W
Eur J Pharmacol. 1979 Sep 1;58(1):11-8. doi: 10.1016/0014-2999(79)90334-0.
For characterisation in vitro, four parallel assays were used: the guinea-pig ileum and mouse vas deferens as pharmacological models at 36 degrees C and the inhibition of binding of [3H]-naltrexone, [3H]-leucine-enkephalin and [3H]-methione-enkephalin at 0 degrees C. The Leu65-analogue of beta-andorphin and its fragments (61-65, 61-76 and 61-77) have a lower affinity to the [3H]-naltrexone binding site of mu-receptors than the corresponding Met65-peptides wereheas no such difference was found for the [3H]leucine-enkephalin binding sites or delta-receptors. When the binding of [3H]-methionine-enkephalin or [3H]-leucine-enkephalin was inhibited by cold ligands interacting with delta-, mu-, or kappa-receptors, no evidence was obtained for more than one type of delta-binding site.
为了进行体外特性鉴定,使用了四种平行测定法:36℃时以豚鼠回肠和小鼠输精管作为药理模型,以及0℃时对[3H] - 纳曲酮、[3H] - 亮氨酸 - 脑啡肽和[3H] - 甲硫氨酸 - 脑啡肽结合的抑制作用。β-内啡肽的Leu65类似物及其片段(61 - 65、61 - 76和61 - 77)对μ受体的[3H] - 纳曲酮结合位点的亲和力低于相应的Met65肽,而对于[3H] - 亮氨酸 - 脑啡肽结合位点或δ受体则未发现此类差异。当与δ、μ或κ受体相互作用的冷配体抑制[3H] - 甲硫氨酸 - 脑啡肽或[3H] - 亮氨酸 - 脑啡肽的结合时,未获得存在不止一种类型δ结合位点的证据。